Sangam G. Goswami

Ghaziabad, UP, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Structure-guided targeting of the GATAD2A-CHD4 interaction within the MBD2-NuRD complex results in high levels of HbF in adult erythroid cells.

Structure-guided targeting of the GATAD2A-CHD4 interaction within the MBD2-NuRD complex results in high levels of HbF in adult erythroid cells.

Journal: bioRxiv : the preprint server for biology

Published: August 01, 2026

CRISPR editing of HPFH3 genotype induces γ-globin expression and reverses sickle cell disease and β-thalassemia phenotypes.

CRISPR editing of HPFH3 genotype induces γ-globin expression and reverses sickle cell disease and β-thalassemia phenotypes.

Journal: Stem cell research & therapy

Published: April 23, 2025

A critical review of therapeutic interventions in sickle cell disease: Progress and challenges.

A critical review of therapeutic interventions in sickle cell disease: Progress and challenges.

Journal: Archiv der Pharmazie

Published: May 16, 2024

CRISPR/Cas9-engineering of Kell null erythrocytes to unveil host targeted irresistible antimalarial.

CRISPR/Cas9-engineering of Kell null erythrocytes to unveil host targeted irresistible antimalarial.

Journal: Communications biology

Published: March 23, 2024

cRGD-modified hybrid lipopolymeric nanoplexes for gene editing in the posterior segment of the eye.

cRGD-modified hybrid lipopolymeric nanoplexes for gene editing in the posterior segment of the eye.

Journal: International journal of biological macromolecules

Published: October 01, 2023

Scalable noninvasive amplicon-based precision sequencing (SNAPseq) for genetic diagnosis and screening of β-thalassemia and sickle cell disease using a next-generation sequencing platform.

Scalable noninvasive amplicon-based precision sequencing (SNAPseq) for genetic diagnosis and screening of β-thalassemia and sickle cell disease using a next-generation sequencing platform.

Journal: Frontiers in molecular biosciences

Published: June 22, 2023

Development of pathophysiologically relevant models of sickle cell disease and β-thalassemia for therapeutic studies.

Development of pathophysiologically relevant models of sickle cell disease and β-thalassemia for therapeutic studies.

Journal: Nature communications

Published: March 12, 2023

Lipopolymeric Nanocarrier Enables Effective Delivery of CRISPR/Cas9 Expressing Plasmid.

Lipopolymeric Nanocarrier Enables Effective Delivery of CRISPR/Cas9 Expressing Plasmid.

Journal: Macromolecular rapid communications

Published: February 26, 2023

Dynamic Palmitoylation of Red Cell Membrane Proteins Governs Susceptibility to Invasion by the Malaria Parasite, Plasmodium falciparum.

Dynamic Palmitoylation of Red Cell Membrane Proteins Governs Susceptibility to Invasion by the Malaria Parasite, Plasmodium falciparum.

Journal: ACS infectious diseases

Published: August 31, 2022

Cationic lipopolymeric nanoplexes containing the CRISPR/Cas9 ribonucleoprotein for genome surgery.

Cationic lipopolymeric nanoplexes containing the CRISPR/Cas9 ribonucleoprotein for genome surgery.

Journal: Journal of materials chemistry. B

Published: August 10, 2022

A Simple, Cost-Effective, and Extraction-Free Molecular Diagnostic Test for Sickle Cell Disease Using a Noninvasive Buccal Swab Specimen for a Limited-Resource Setting.

A Simple, Cost-Effective, and Extraction-Free Molecular Diagnostic Test for Sickle Cell Disease Using a Noninvasive Buccal Swab Specimen for a Limited-Resource Setting.

Journal: Diagnostics (Basel, Switzerland)

Published: June 08, 2022

Development of an efficient single-cell cloning and expansion strategy for genome edited induced pluripotent stem cells.

Development of an efficient single-cell cloning and expansion strategy for genome edited induced pluripotent stem cells.

Journal: Molecular biology reports

Published: December 29, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026